Protego Biopharma Appoints John M. Maraganore, Ph.D., to Board of Directors
Dr. Maraganore brings more than three decades of experience leading discovery, development and commercialization of groundbreaking medicines Founding CEO of Alnylam Pharmaceuticals led company through global approval and commercialization of its first five RNAi medicines SAN DIEGO, Calif., March 3, 2026 — Protego Biopharma, Inc., a clinical-stage biotechnology company dedicated to pioneering first-in-class small […]